KdT Ventures

KdT Ventures is a venture capital firm specializing in early-stage frontier science investing. They focus on companies re-architecting the world at a molecular level, particularly in chemistry and biology. Their unique model allows for significant impact in the earliest stages of a venture.

KdT Ventures favicon
Founded 2017 ยท Venture Capital
San Francisco (United States), Austin (United States), Durham (United States), Chicago (United States)
Investment Stages
Seed
Series A
Markets
Biotechnology
Therapeutics
Genomics
AI
Medical Technology
Agriculture
Materials Science
Portfolio Companies

PathAI, Tavros Therapeutics, Remedy Robotics, Elegen, Checkerspot, STRM.BIO, Solugen, Terray Therapeutics, Dyno Therapeutics, Debut Biotechnology, 54Gene, Abridge, Azitra, Elemental Machines, Hi Fidelity Genetics, Patch'd, Rejuvenate Bio, Theator, Tierra Biosciences, Braid Health, Andes, Circularis, Xilis, Revel, Dimension Inx, Onc.AI, Faeth, SeQure, Marigold Health, Parthenon, Modulus, Zymochem, Molecule, Cypris Materials, Canaery, Tacit Therapeutics, Equii, Character, Elo Life Systems, Nosis Bio, Aperiam Bio, Perceptive, Syenex, March Bio

Share this page